X hits on this document

96 views

0 shares

0 downloads

0 comments

14 / 34

2132

TABLE 5 (continued)

CANCER

e

b

Non-Hispanic

APC

d

Rate

Rank

e

APC

bc

Hispanic

d

Rate

Rank

e

AI/AN (CHSDA counties)

b

APC

d

Rate

Rank

e

APC

b

AI/AN

d

Rate

Rank

e

APC

b

API

d

Rate

Rank

e

APC

b

Black

d

Rate

Rank

e

APC

b

White

d

Rate

Rank

e

All races/ethnicities

APC

d

Rate

Rank

a

Sex/cancer site or type

f f

2.6 2.6

1.6 0.8

18 20

f

0.5 5.2

0.8 1.4

19 15

1.5 2.3

17 14

1.3 1.5

16 14

f

2.3 4.0

1.3 0.8

14 17

f

4.5 1.2

1.7 1.0

17 19

f f

2.3 3.0

1.5 0.8

18 20

f f

2.5 2.8

1.5 0.8

18 20

Oral cavity and pharynx Gallbladder

a

b

c

Source: National Center for Health Statistics public-use data file for the total U.S. API indicates Asian/Pacific Islander; AI/AN, American Indian/Alaska Native; CHSDA, Indian Health Service Contract Health Service Delivery Area; APC, annual percent change; NOS, not otherwise specified. Cancers are sorted in descending order according to sex-specific rates for all races/ethnicities. Greater than 15 cancers may appear under males and females to include the top 15 cancers in every race/ethnicity group. White, black, API, AI/AN, and AI/AN (CHSDA counties) include Hispanic and non-Hispanic; the race and ethnicity categories are not mutually exclusive. Data for Hispanic exclude Maine, Minnesota, New Hampshire, North Dakota, and Oklahoma. Rates are per 100,000 persons and were age-adjusted to the 2000 U.S. standard population (19 age groups, Census p25–1130). APC is based on rates that were age-adjusted to the 2000 U.S. standard population (19 age groups; Census, p251130). APC is statistically significantly different from zero (2-sided P <.05). Statistic could not be calculated. The APC is based on < 10 cases for at least 1 year within the time interval.

d

e

f

Cancer Incidence Cancer incidence rates in AI/AN persons for all can- cers combined were lower than for NHW persons for all regions combined (Tables 7 and 8). However, inci- dence rates varied by geographic region and cancer site. Among AI/AN men, cancer incidence rates for all sites combined ranged from 262 per 100,000 men in the Southwest to 611 per 100,000 men in the Northern Plains compared with the rates in NHW men, which ranged from 513 per 100,000 men in the Southwest to 578 per 100,000 men in the East. Among AI/AN women, the cancer incidence rates ranged from 219 per 100,000 women in the South- west to 511 per 100,000 women in Alaska compared with a range from 404 per 100,000 women in the

November 15, 2007 / Volume 110 / Number 10

Current smoking prevalence among persons aged

  • 18 years was higher among AI/AN persons overall

than among NHW persons, with the highest preva- lence among AI/AN populations in Alaska and the Northern Plains (Table 6). Smoking prevalence among AI/AN was the lowest in the Southwest and did not differ greatly from that among NHW. In all regions, more AI/AN than NHW men and women aged 20 years reported being obese; and, corre- spondingly, more AI/AN than NHW persons aged

  • 18 years reported no leisure time physical activity.

Whereas heavy drinking was more common among men than among women in both populations, the percentage of AI/AN persons aged 18 years who consumed 5 drinks on 1 occasion was higher over- all than that of NHW adults. The estimates for AI/AN in the individual regions were less stable; however, in Alaska and in the Northern Plains, both AI/AN men and AI/AN women had a higher prevalence of heavy drinking than NHW. In the Southwest, this was true for AI/AN men only.

The prevalence of cancer screening was lower among AI/AN than NHW persons and varied widely across IHS regions (Table 6). Mammography screen- ing was lower among AI/AN women than among NHW women, with the lowest AI/AN prevalence esti- mates in the Pacific Coast and Southwest. Similarly, among AI/AN men and women aged 50 years, fecal occult blood testing (FOBT) and endoscopy within the past 5 years were lower than that among NHW men and women. The prevalence of endoscopy for the AI/AN population in the Southwest was half the prevalence for the NHW population. Pap testing prevalence was lowest for AI/AN women in the Southern Plains and the East and was higher for Alaskan AI/AN women than for NHW women. Simi- larly, the prevalence of PSA testing was lower for AI/ AN men than for NHW men.

Document info
Document views96
Page views96
Page last viewedSun Dec 11 02:48:28 UTC 2016
Pages34
Paragraphs3857
Words25693

Comments